-Conference Call
Trevi Therapeutics Priced ~14.25M Share Public Offering of Common Stock @$1.93/Share
Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced the pricing of its underwritten public offering of 14,252,670 shares of its common stock at a public offering price of $1.93 per share, and, to certain investors in lieu of common stock, pre-funded warrants to purchase 14,247,330 shares of common stock at a price of $1.92
